BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 20639476)

  • 1. Functional role and prognostic significance of CD157 in ovarian carcinoma.
    Ortolan E; Arisio R; Morone S; Bovino P; Lo-Buono N; Nacci G; Parrotta R; Katsaros D; Rapa I; Migliaretti G; Ferrero E; Volante M; Funaro A
    J Natl Cancer Inst; 2010 Aug; 102(15):1160-77. PubMed ID: 20639476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients.
    Mezzanzanica D; Fabbi M; Bagnoli M; Staurengo S; Losa M; Balladore E; Alberti P; Lusa L; Ditto A; Ferrini S; Pierotti MA; Barbareschi M; Pilotti S; Canevari S
    Clin Cancer Res; 2008 Mar; 14(6):1726-33. PubMed ID: 18347173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
    Tsai MF; Wang CC; Chang GC; Chen CY; Chen HY; Cheng CL; Yang YP; Wu CY; Shih FY; Liu CC; Lin HP; Jou YS; Lin SC; Lin CW; Chen WJ; Chan WK; Chen JJ; Yang PC
    J Natl Cancer Inst; 2006 Jun; 98(12):825-38. PubMed ID: 16788156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker.
    Yousef GM; Kyriakopoulou LG; Scorilas A; Fracchioli S; Ghiringhello B; Zarghooni M; Chang A; Diamandis M; Giardina G; Hartwick WJ; Richiardi G; Massobrio M; Diamandis EP; Katsaros D
    Cancer Res; 2001 Nov; 61(21):7811-8. PubMed ID: 11691797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of dedicator of cytokinesis I (Dock180) in ovarian cancer correlated with aggressive phenotype and poor patient survival.
    Zhao F; Siu MK; Jiang L; Tam KF; Ngan HY; Le XF; Wong OG; Wong ES; Chan HY; Cheung AN
    Histopathology; 2011 Dec; 59(6):1163-72. PubMed ID: 22175896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of human leukocyte antigen-G (HLA-G) expression and disease progression in epithelial ovarian cancer.
    Jung YW; Kim YT; Kim SW; Kim S; Kim JH; Cho NH; Kim JW
    Reprod Sci; 2009 Nov; 16(11):1103-11. PubMed ID: 19692629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
    Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor D and intratumoral lymphatics as independent prognostic factors in epithelial ovarian carcinoma.
    Li L; Liu B; Li X; Yang S; Xiao J; Chen M; Zhang Y; Ma J
    Anat Rec (Hoboken); 2009 Apr; 292(4):562-9. PubMed ID: 19226617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative serum tissue factor levels are an independent prognostic factor in patients with ovarian carcinoma.
    Han LY; Landen CN; Kamat AA; Lopez A; Bender DP; Mueller P; Schmandt R; Gershenson DM; Sood AK
    J Clin Oncol; 2006 Feb; 24(5):755-61. PubMed ID: 16380413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
    Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K
    Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ErbB-3 predicts survival in ovarian cancer.
    Tanner B; Hasenclever D; Stern K; Schormann W; Bezler M; Hermes M; Brulport M; Bauer A; Schiffer IB; Gebhard S; Schmidt M; Steiner E; Sehouli J; Edelmann J; Läuter J; Lessig R; Krishnamurthi K; Ullrich A; Hengstler JG
    J Clin Oncol; 2006 Sep; 24(26):4317-23. PubMed ID: 16896008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
    Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
    Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of glia maturation factor beta as an independent prognostic predictor for serous ovarian cancer.
    Li YL; Ye F; Cheng XD; Hu Y; Zhou CY; Lü WG; Xie X
    Eur J Cancer; 2010 Jul; 46(11):2104-18. PubMed ID: 20547056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of CD157 contributes to epithelial ovarian cancer progression by promoting mesenchymal differentiation.
    Morone S; Lo-Buono N; Parrotta R; Giacomino A; Nacci G; Brusco A; Larionov A; Ostano P; Mello-Grand M; Chiorino G; Ortolan E; Funaro A
    PLoS One; 2012; 7(8):e43649. PubMed ID: 22916288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer.
    Kaifi JT; Yekebas EF; Schurr P; Obonyo D; Wachowiak R; Busch P; Heinecke A; Pantel K; Izbicki JR
    J Natl Cancer Inst; 2005 Dec; 97(24):1840-7. PubMed ID: 16368946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the focal adhesion protein kindlin-1 in breast cancer growth and lung metastasis.
    Sin S; Bonin F; Petit V; Meseure D; Lallemand F; Bièche I; Bellahcène A; Castronovo V; de Wever O; Gespach C; Lidereau R; Driouch K
    J Natl Cancer Inst; 2011 Sep; 103(17):1323-37. PubMed ID: 21832234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular cell adhesion molecule-1 is a regulator of ovarian cancer peritoneal metastasis.
    Slack-Davis JK; Atkins KA; Harrer C; Hershey ED; Conaway M
    Cancer Res; 2009 Feb; 69(4):1469-76. PubMed ID: 19208843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of trypsinogen-1, trypsinogen-2, and tumor-associated trypsin inhibitor in ovarian cancer: prognostic study on tissue and serum.
    Paju A; Vartiainen J; Haglund C; Itkonen O; von Boguslawski K; Leminen A; Wahlström T; Stenman UH
    Clin Cancer Res; 2004 Jul; 10(14):4761-8. PubMed ID: 15269150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD157 is part of a supramolecular complex with CD11b/CD18 on the human neutrophil cell surface.
    Lavagno L; Ferrero E; Ortolan E; Malavasi F; Funaro A
    J Biol Regul Homeost Agents; 2007; 21(1-2):5-11. PubMed ID: 18211745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.